JenaValve Technology, Inc. announced that it has entered into series B purchase agreement and will issue 2,800,000 series B preferred shares at a price of $13.6074 per share for the gross proceeds of $38,100,720 on January 6, 2019. The shares will be convertible into common shares at a fixed conversion price of $13.6074 per share. The company will receive $14,491,952 pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.75 EUR | -1.69% |
|
-11.41% | -8.01% |
06-25 | Belgium's Gimv to Acquire Belfius Insurance's Stake in TINC | MT |
06-25 | Gimv NV agreed to acquire 10.69% stake in TINC NV from Belfius Insurance SA ?45.75 million. | CI |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.01% | 1.32B | |
-6.64% | 93.99B | |
+26.14% | 93.39B | |
+14.53% | 26.55B | |
-8.84% | 16.95B | |
-2.73% | 14.45B | |
+0.57% | 13.13B | |
-25.71% | 11.76B | |
+28.23% | 10.23B | |
+19.53% | 9.24B |
- Stock Market
- Equities
- GIMB Stock
- News Gimv NV
- JenaValve Technology, Inc. announced that it expects to receive $38.10072 million in funding from a group of investors